These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21652790)

  • 21. Potential for pregabalin abuse or diversion after past drug-seeking behavior.
    Filipetto FA; Zipp CP; Coren JS
    J Am Osteopath Assoc; 2010 Oct; 110(10):605-7. PubMed ID: 21068226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second-generation thiazolidinediones and hepatotoxicity.
    Marcy TR; Britton ML; Blevins SM
    Ann Pharmacother; 2004 Sep; 38(9):1419-23. PubMed ID: 15266041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.
    Arnold LM; Emir B; Murphy TK; Zeiher BG; Pauer L; Scott G; Petersel D
    Clin Ther; 2012 May; 34(5):1092-102. PubMed ID: 22503162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study.
    Solaro C; Boehmker M; Tanganelli P
    J Neurol; 2009 Oct; 256(10):1773-4. PubMed ID: 19579001
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost-utility of pregabalin as add-on to usual care versus usual care alone in the management of peripheral neuropathic pain in Belgium.
    Chevalier P; Lamotte M; Van Campenhout H; Eyckerman R; Annemans L
    J Med Econ; 2013; 16(5):596-605. PubMed ID: 23409950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral edema with pregabalin.
    Gallagher R; Apostle N
    CMAJ; 2013 Jul; 185(10):E506. PubMed ID: 23128284
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of gabapentin and pregabalin for hand surgery patients.
    Brunton LM; Laporte DM
    J Hand Surg Am; 2012 Jul; 37(7):1486-8. PubMed ID: 22721460
    [No Abstract]   [Full Text] [Related]  

  • 28. Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study.
    Gatti A; Sabato AF; Occhioni R; Colini Baldeschi G; Reale C
    Eur Neurol; 2009; 61(3):129-37. PubMed ID: 19092248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gabapentin versus pregabalin in relieving early post-surgical neuropathic pain in patients after lumbar disc herniation surgery: a prospective clinical trial.
    Dolgun H; Turkoglu E; Kertmen H; Gurer B; Yilmaz ER; Comoglu SS; Sekerci Z
    Neurol Res; 2014 Dec; 36(12):1080-5. PubMed ID: 24938318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of pregabalin in patients with spinal cord injury: a pooled analysis.
    Parsons B; Sanin L; Yang R; Emir B; Juhn M
    Curr Med Res Opin; 2013 Dec; 29(12):1675-83. PubMed ID: 23998397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gabapentin and pregabalin: hepatic and haematological toxicity.
    Prescrire Int; 2014 Nov; 23(154):267. PubMed ID: 25954794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis associated with low-dose venlafaxine for postmenopausal vasomotor symptoms.
    Phillips BB; Digmann RR; Beck MG
    Ann Pharmacother; 2006 Feb; 40(2):323-7. PubMed ID: 16418323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost savings associated with early initiation of pregabalin in the management of peripheral neuropathic pain.
    Pérez C; Navarro A; Saldaña MT; Figueras-Balsells M; Muñoz-Tudurí M; Rejas J
    Clin J Pain; 2013 Jun; 29(6):471-7. PubMed ID: 23328322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors predicting adverse events associated with pregabalin administered for neuropathic pain relief.
    Kanbayashi Y; Onishi K; Hosokawa T
    Pain Res Manag; 2014; 19(6):e164-7. PubMed ID: 24945288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners in the U.K.
    Berger A; Sadosky A; Dukes E; Edelsberg J; Oster G
    Pain Pract; 2009; 9(1):18-34. PubMed ID: 19019054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief.
    Stacey BR; Barrett JA; Whalen E; Phillips KF; Rowbotham MC
    J Pain; 2008 Nov; 9(11):1006-17. PubMed ID: 18640074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Gore M; Sadosky A; Tai KS; Stacey B
    Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregabalin hypersensitivity in a patient treated for postherpetic neuralgia.
    Bamanikar A; Dhobale S; Lokwani S
    Indian J Pharmacol; 2013; 45(5):522-3. PubMed ID: 24130391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregabalin for the treatment of postsurgical pain.
    Durkin B; Page C; Glass P
    Expert Opin Pharmacother; 2010 Nov; 11(16):2751-8. PubMed ID: 20977407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia.
    Sharma U; Griesing T; Emir B; Young JP
    Am J Ther; 2010; 17(6):577-85. PubMed ID: 20393345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.